Beta-caryophyllene inhibits the permeability of the blood–brain barrier in MPTP-induced parkinsonism
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta-caryophyllene inhibits the permeability of the blood–brain barrier in MPTP-induced parkinsonism
Authors
Keywords
-
Journal
NEUROLOGIA
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-08-05
DOI
10.1016/j.nrl.2022.11.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress and regulated cell death in Parkinson’s disease
- (2021) P.A. Dionísio et al. AGEING RESEARCH REVIEWS
- Neonatal excitotoxicity modifies blood-brain barrier properties increasing its susceptibility to hypertonic shock in adulthood
- (2020) Blanca Fabiola Fajardo-Fregoso et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention
- (2020) Plamena R. Angelova et al. MEDICINAL RESEARCH REVIEWS
- Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders
- (2020) Jeffrey J. Lochhead et al. Frontiers in Physiology
- Microglia and astrocyte dysfunction in parkinson's disease
- (2020) Tae-In Kam et al. NEUROBIOLOGY OF DISEASE
- β-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson’s disease
- (2020) M.E. Flores-Soto et al. NEUROSCIENCE LETTERS
- Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage
- (2019) Shotaro Michinaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- P53-induced reduction of lipid peroxidation supports brain microvascular endothelium integrity
- (2019) Mohammad S. Akhter et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- PPAR-γ promotes p38 MAP kinase-mediated endothelial cell permeability through activating Sirt3
- (2019) Zhenzhen Zhao et al. BMC Neurology
- The Blood–Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders
- (2019) Laura Costea et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A cannabinoid receptor 2 agonist reduces blood–brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats
- (2018) Lin Li et al. BRAIN RESEARCH
- Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway
- (2018) Min Gi Jo et al. MOLECULAR NEUROBIOLOGY
- Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of blood–brain barrier integrity
- (2018) Jong Hee Choi et al. Journal of Ginseng Research
- Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors
- (2018) Dareen A. Youssef et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- (2017) Michael G. Erkkinen et al. Cold Spring Harbor Perspectives in Biology
- Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor
- (2017) F. Guida et al. Scientific Reports
- Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
- (2016) Yolanda Gómez-Gálvez et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
- (2016) Hayate Javed et al. Frontiers in Neuroscience
- Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume
- (2015) Tom J. van Mierlo et al. MOVEMENT DISORDERS
- Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease
- (2015) María Concepción García et al. NEUROSCIENCE LETTERS
- Human kidney podocyte cell population as a novel biological target of nerve growth factor
- (2014) Maria Cristina Caroleo et al. GROWTH FACTORS
- Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia
- (2014) Kexin Guo et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model
- (2014) Sumit Sarkar et al. NEUROTOXICOLOGY
- Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease
- (2014) Ricardo Cabezas et al. Frontiers in Cellular Neuroscience
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- Prospects for cannabinoid therapies in basal ganglia disorders
- (2011) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Increased Blood–Brain Barrier Permeability and Brain Edema After Focal Cerebral Ischemia Induced by Hyperlipidemia
- (2011) Ayman ElAli et al. STROKE
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now